Short- and long-term effects of early fosinopril administration in patients with acute anterior myocardial infarction undergoing intravenous thrombolysis: Results from the Fosinopril in Acute Myocardial Infarction Study

American Heart Journal

Volumn 136, Issue 2, 1998, Pages 213-225

  Borghi, Claudio ^a   Marino, Paolo ^b   Zardini, Piero ^b   Magnani, Bruno ^b   Collatina, Stefano ^b   Ambrosioni, Ettore ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; FOSINOPRIL; NITRIC ACID DERIVATIVE; PLACEBO;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HEART DEATH; HEART LEFT VENTRICLE VOLUME; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0031820940     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1053/hj.1998.v136.89745     Document Type: Article

References (45)

1. Jeremy RW, Allman KC, Bautovitch G, Harris PJ. Patterns of ventricular dilatation during the six months after myocardial infarction. J Am Coll Cardiol 1989;13:304-31.
2. Lamas GA. Left ventricular dilatation following myocardial infarction: clinical course and potential for therapy. Cardiology 1989;76:112-21.
3. White HD, Morris RM, Brown MA, Brandt PWT, Withlock RML, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987;76:44-51.
4. Cairns JA, Collins R, Fuster V, Passamani ER. Coronary thrombolysis. Chest 1989;95:73S-87S.
5. Kingma JH, van Gilst WH, Peels CH, et al. Acute intervention with captopril during thrombolysis in patients with first anterior myocardial infarction: results from the CATS Study. Eur Heart J 1994;15:898-907.
6. Nabel EG, Topol EJ, Galeana A, et al. A randomized placebo-controlled trial of combined early intravenous captopril and recombinant tissue-type plasminogen activator therapy in acute myocardial infarction. J Am Coll Cardiol 1991;17:467-73.
7. Ambrosioni E, Borghi C, Magnani B, on behalf of the SMILE Study Investigators. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. N Engl J Med 1995:332;80-5.
8. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993;342:821-8.
9. Kober L, Torp-Pedersen C, Carlsen JE, et al, for TRACE Study Group. A clinical trial of the angiotensin converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1995;333:1670-6.
10. ISIS-4 Collaborative group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction. Lancet 1995;345:669-85.
11. Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E. Effects of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med 1988;319:80-6.
12. Chikvashvili DJ, Sokirka GM, Ruda MY. Effects of early captopril administration following myocardial infarction: which patients benefit best [abstract]? Eur Heart J 1994;15:327.
13. Ray SG, Pye M, Oldroyd KG, et al. Early treatment with captopril after acute myocardial infarction. Br Heart J 1993;69:215-22.
14. Gueret P, Himbert P, Massabuau P, et al. The effects of early administration of captopril on left ventricular remodeling after acute myocardial infarction are related to infarct size [abstract]. Proceedings of the 2nd International Symposium on ACE-inhibitors. Amsterdam: 1993;229.
15. Sharpe N, Smith H, Murphy J, Greaves S, Hart H, Gamble G. Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin converting enzyme inhibition. Lancet 1991;337:872-6.
16. Bazzino O, Navarro Estrada J, Sosa Liprandi A, et al. Early treatment with low dose enalapril prevents left ventricular dilatation after acute myocardial infarction [abstract]. Circulation 1992;86:1-313.
17. Bonaduce D, Petretta M, Arrichiello P, et al. Effects of captopril treatment on left ventricular remodeling and function after anterior myocardial infarction: comparison with digitalis. J Am Coll Cardiol 1992;19:858-63.
18. Galcera-Tomas J, Nuno-De La Rosa JA, Torres-Martinez G, et al. Effects of early use of captopril on hemodynamics and short-term ventricular remodeling in acute anterior myocardial infarction. Eur Heart J 1993;14:259-66.
19. Kyriakidis MK, Petropulakis PN, Georgiou EK, et al. The effects of early captopril treatment on left ventricular volumes and function in patients with and without depressed global ejection fraction after acute myocardial infarction. Eur Heart J 1993;14:1692-700.
20. Kugler I, Gaudron K, Eilles C, Ertl G. Small myocardial infarction may cause slow remodelling with late ventricular dilatation and dysfunction [abstract]. Eur Heart J 1996;17:259.
21. Darasz KH, Bayliss J, Underwood SR, et al. Left ventricular volume in thrombolyzed patients with acute anterior myocardial infarction: the effects of captopril and xamoterol. Int J Cardiol 1995;51:137-42.
22. Guthrie R. Fosinopril: an overview. Am J Cardiol 1993;72:22H-4H.
23. Sheehan FH, Bolson MS, Dodge HT, Mathey DG, Schofer J, Woo HW. Advantages and applications of the centerline method for characterizing regional ventricular function. Circulation 1986;74:293-305.
24. Silverman HN, Ports TA, Snider AR, Sgiller NB, Carlsson E, Heibron DC. Determination of left ventricular volume in children: echocardiographic and angiographic comparisons. Circulation 1980;62:548-57.
25. Schiller NB. Two-dimensional echocardiographic determination of left ventricular volume, systolic function, and mass. Circulation 1991;84(suppl 1):280-7.
26. Schulman S, Gerstenblith G, Guerci A, et al. Effect of early enalapril therapy on left ventricular volumes in acute myocardial infarction [abstract]. J Am Coll Cardiol 1993;21:370A.
27. Hochman JS, Edelstein R, Palmieri S, et al. Captopril before reperfusion in acute myocardial infarction: the CAPTIN experience. J Am Coll Cardiol 1993;2(suppl 21):371A.
28. Hall AS, Murray GD, Ball SG. Follow-up study of patients randomly allocated ramipril or placebo for heart failure after acute myocardial infarction: AIRE Extension (AIREX) Study. Lancet 1997;349:1493-7.
29. Litwin SE, Katz SE, Morgan JP, et al. Long-term captopril treatment improves diastolic filling more than systolic performance in rats with large myocardial infarction. J Am Coll Cardiol 1996;28:773-81.
30. Hochman JS, Srichai MB, Picard M, et al. Very early ACE-inhibition reduces progressive left ventricular dilatation when t-PA fails to establish early reperfusion during acute anterior myocardial infarction [abstract]. Circulation 1994;90:1-26.
31. Borghi C, Ambrosioni E, Magnani B, on behalf of the SMILE Working Party. Effects of the early administration of zofenopril on onset and progression of congestive heart failure in patients with anterior wall acute myocardial infarction. Am J Cardiol 1996;78:317-32.
32. Bader M, et al. The role of the renin-angiotensin system in cardiovascular disease. Hypertens Res 1994;17:1-16.
33. Tan LB, Jalil JE, Pick R, Janicki JS, Weber KT. Cardiac myocyte necrosis induced by angiotensin II. Circ Res 1991;69:1185-95.
34. Oskarsson HJ, Heistad DH. Oxidative stress produced by angiotensin II: implications for hypertension and vascular injury. Circulation 1997;95:557-9.
35. Hall AS, Murray GD, Ball SG. Lancet. 1997;349:1493-7.
36. Litwin SE, Katz SE, Morgan JP, et al. J Am Coll Cardiol 1993;21:410A.
37. Goetzsch C-O, Sogaard P, Ravkilde J, Thygesen K. Effects of captopril on left ventricular systolic and diastolic function after acute myocardial infarction. Am J Cardiol 1992;70:156-60.
38. Mendes LA, Davidoff R, Cupples LA, Ryan TJ, Jacobs AK. Congestive heart failure in patients with coronary artery disease: the gender paradox. Am Heart J 1997:134:207-12.
39. The Multicenter Postinfarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med 1983;309:331-6.
40. O'Connor CM, Hathaway WR, Bates ER, et al. Clinical characteristics and long-term outcome of patients whom congestive heart failure develops after thrombolytic therapy for acute myocardial infarction: development of a predictive model. Am Heart J 1997;133:663-73.
41. Swedberg K, Held P, Kjekshus J, et al. Effect of the early administration of enalapril on mortality in patients with acute myocardial infarction: results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II). N Engl J Med 1992;327:678-84.
42. Latini R, Maggioni AP, Flather M, Sleight P, Tognoni G. ACE-inhibitors use in patients with myocardial infarction: summary of evidence from clinical trials. Circulation 1995;92:3132-7.
43. Pfeffer MA, Greaves SC, Arnold MO, et al. Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction: the Healing and Early Afterload Reducing Therapy Trial. Circulation 1997;95:2643-51.
44. Prewitt RM, Gu S, Garber PJ, Ducas J. Marked systemic hypotension depresses coronary thrombolysis induced by intracoronary administration of recombinant tissue-type plasminogen activator. J Am Coll Cardiol 1992;20:1626-33.
45. de Graeff PA, de Langen CDJ, Bel K, Scholtens E, et al. Protective effects of captopril against ischemia\reperfusion- induced ventricular arrhythmias in vitro and in vivo. Am J Med 1988;84(suppl 3A):67.